AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.

Latest News

Company updates from every Merlintrader stock hub

Every company update collected in our stock hubs, in one dated list: biotech, space, defense, AI, energy, critical minerals and more. Each headline opens the company’s hub on Merlintrader, and the tag on the right links to the original document, such as the company release, the SEC filing or the clinical trial record. The list updates automatically several times a day; times, when shown, are US Eastern.

Stars rate how significant each update is, from 1 (routine notice) to 5 (major event such as an FDA decision, a merger or pivotal trial results). The rating is assigned automatically by type of news and is not an investment opinion.

DateImportanceHeadlineTickerSource
4:37 PM ET★★★★★Ondas files prospectus supplement covering resale of 6,292 sharesONDSFiling · SEC
4:25 PM ET★★★★★Starfighters Space files prospectus supplement covering 5,223,879 common sharesFJETFiling · SEC
4:15 PM ET★★★★★ProKidney Names Farah Ali, M.D., M.S., Chief Medical OfficerPROKRelease · GlobeNewswire
4:15 PM ET★★★★★Zenas BioPharma announces inducement grants under Nasdaq Listing Rule 5635(c)(4)ZBIORelease · GlobeNewswire
4:10 PM ET★★★★★Abeona files S-3 to register 12,494,426 shares for resale by selling stockholdersABEOFiling · SEC
4:05 PM ET★★★★★Geron Corporation reports inducement grants under Nasdaq Listing Rule 5635(c)(4)GERNRelease · GlobeNewswire
4:05 PM ET★★★★★BillionToOne responds to inaccurate and misleading short seller reportBLLNRelease · GlobeNewswire
4:04 PM ET★★★★★Madrigal Pharmaceuticals announces grants of inducement awards under Nasdaq Listing Rule 5635(c)(4)MDGLRelease · GlobeNewswire
3:23 PM ET★★★★★Genmab announces grant of restricted stock units and warrants to employeesGMABFiling · SEC
★★★★★Arcus Biosciences to participate in two upcoming investor conferencesRCUSRelease · Business Wire
2:49 PM ET★★★★★Report: Len Blavatnik holds roughly $5 billion SpaceX stake via Access IndustriesSPCXNews
2:49 PM ET★★★★★Nvidia halts Hopper chip shipments to China, models no revenue from those salesNVDANews
2:36 PM ET★★★★★SpotlightAI demining technology wins Scalable Innovation award at Mine Action Innovation AwardsSPAINews
2:13 PM ET★★★★★FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher DiseaseRegulatory · FDA
2:02 PM ET★★★★★Report: Search firm sounds out Arm CEO Rene Haas for Nvidia chief executive roleNVDANews
2:01 PM ET★★★★★Jefferies says Waymo expansion has limited impact on Uber bookings growth, raises estimatesUBERNews
★★★★★Amkor Technology announces increases in quarterly dividendAMKRRelease · Business Wire
12:27 PM ET★★★★★Cantor says its Nvidia holdings hedge client swaps, not proprietary positionsNVDANews
11:30 AM ET★★★★★Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year PartnershipONDSRelease · ACCESS Newswire
11:20 AM ET★★★★★Morgan Stanley lowers Recursion price target to $5.60, keeps Equal-WeightRXRXNews
11:17 AM ET★★★★★JP Morgan lifts Nvidia price target to $230, keeps Overweight ratingNVDANews
11:14 AM ET★★★★★Citi says SpaceX mobile network would still need many macro cell sitesSPCXNews
★★★★★AST SpaceMobile details 780,052 shares for spectrum obligationsASTSFiling · SEC
10:57 AM ET★★★★★Morgan Stanley lifts Disc Medicine price target to $104, maintains Overweight ratingIRONNews
10:50 AM ET★★★★★UBS lowers Nvidia price target to $220 from $240, keeps BuyNVDANews
10:28 AM ET★★★★★BMO Capital lifts BrightSpring price target to $84 from $80BTSGNews
10:15 AM ET★★★★★House committee seeks briefing from Nvidia interim CEO Colette Kress on chip exportsNVDANews
10:02 AM ET★★★★★Princess Cruises Selected as a Good Housekeeping 2027 Travel Awards WinnerCCLRelease · PR Newswire
9:54 AM ET★★★★★TD Cowen lowers BWX Technologies price target to $180 from $230BWXTNews
9:50 AM ET★★★★★B. Riley Securities lowers United States Antimony price target to $6 from $10UAMYNews
9:45 AM ET★★★★★Wells Fargo lowers ORIC Pharmaceuticals price target to $23 from $25ORICNews
★★★★★New Novo Nordisk study of zenagamtide fasting and dosing interruption registeredNVOTrial · ClinicalTrials.gov
★★★★★Xenon's azetukalner major depressive disorder Phase 3 study status now terminatedXENETrial · ClinicalTrials.gov
9:21 AM ET★★★★★Oppenheimer lifts Viatris price target to $26 from $25, keeps OutperformVTRSNews
9:21 AM ET★★★★★FDA releases complete response letter explaining ivonescimab rejection for lung cancerSMMTNews
9:17 AM ET★★★★★Oppenheimer lowers Acadia Pharmaceuticals price target to $21 from $23ACADNews
★★★★★Palladyne AI publishes November 2026 investor overview presentation, NASDAQ: PDYNPDYNRelease · SEC
★★★★★Immuneering registers Phase 2 atebimetinib study in advanced or metastatic NSCLCIMRXTrial · ClinicalTrials.gov
★★★★★Aleniglipron Renal Impairment Study Registered on ClinicalTrials.govGPCRTrial · ClinicalTrials.gov
9:02 AM ET★★★★★Guggenheim lowers Entrada Therapeutics price target to $13 from $17TRDANews
9:01 AM ET★★★★★Guggenheim lowers Ionis price target to $65 from $80, maintains Buy ratingIONSNews
9:00 AM ET★★★★★Northland Capital raises Camtek rating to Outperform, sets $130 price targetCAMTNews
8:39 AM ET★★★★★Wedbush lifts Nvidia price target to $293, maintains Outperform ratingNVDANews
8:35 AM ET★★★★★Dermata announces U.S. trademark registration for TOME®DRMARelease · ACCESS Newswire
8:35 AM ET★★★★★Moleculin strengthens global intellectual property portfolio around Annamycin, secures Korean patent allowanceMBRXRelease · GlobeNewswire
8:05 AM ET★★★★★BillionToOne to participate in the Piper Sandler 38th Annual Healthcare ConferenceBLLNRelease
8:05 AM ET★★★★★INOVIO Submits Conditional Marketing Authorization Application to European Medicines Agency for VOCERYQINORelease · PR Newswire
★★★★★Starfighters Space Signs Letter of Intent for High-Speed Flight Test and Launch CorridorFJETRelease · Business Wire
★★★★★Verastem Announces Late-Breaking Oral Presentation of VS-7375 Lung Cancer Data at IASLC/ASCO 2026VSTMRelease · Business Wire
★★★★★Hims & Hers launches Peptides+, a new clinically-guided specialty for personalized, proactive healthHIMSRelease · Business Wire
8:00 AM ET★★★★★Scribe Therapeutics presents new data for ultra-long-acting genetic medicines in cardiovascular diseaseSCTXRelease · GlobeNewswire
7:40 AM ET★★★★★Report: House Democrats ask Cantor for Nvidia holdings records amid Megaspeed export scrutinyNVDANews
7:38 AM ET★★★★★Piper Sandler lowers Nvidia price target to $230 from $300NVDANews
7:33 AM ET★★★★★Summit Insights cuts Nvidia rating to HoldNVDANews
7:30 AM ET★★★★★H.C. Wainwright lowers uniQure price target to $65 from $80QURENews
7:30 AM ET★★★★★Yorkville Ives keeps outperform rating on Nvidia with $225 price target after record quarterNVDANews
7:30 AM ET★★★★★Immuneering Presents Data Supporting Clinical Evaluation of Atebimetinib in Anaplastic Thyroid CancerIMRXRelease · GlobeNewswire
7:30 AM ET★★★★★Immuneering Presents Additional Data on Atebimetinib as Backbone for Pancreatic Cancer CombinationsIMRXRelease · GlobeNewswire
7:30 AM ET★★★★★Zevra Therapeutics to Present at the Piper Sandler Annual Healthcare ConferenceZVRARelease · GlobeNewswire
7:29 AM ET★★★★★Morgan Stanley lowers Nvidia price target to $260, keeps OverweightNVDANews
7:28 AM ET★★★★★Deliverect reaches top Premier tier in Uber Partner Network for Eats and DirectUBERNews
7:24 AM ET★★★★★Bernstein downgrades Summit Therapeutics to Underperform and lowers price target to $8.30SMMTNews
7:12 AM ET★★★★★Wells Fargo cuts Nvidia price target to $250; Barclays and Citi keep ratings after resultsNVDANews
7:03 AM ET★★★★★Nvidia outlines about 75% fiscal 2028 revenue growth, cites $2.5 trillion cloud backlogNVDANews
7:00 AM ET★★★★★Can-Fite pivotal Phase III psoriasis study completes dosing; interim analysis expected Q1 2027CANFRelease · SEC
7:00 AM ET★★★★★Aquestive Therapeutics to present at the Piper Sandler 38th Annual Healthcare ConferenceAQSTRelease · GlobeNewswire
7:00 AM ET★★★★★American Resources Corporation provides strategic business and financial reporting updateARECRelease · ACCESS Newswire
6:58 AM ET★★★★★Key information relating to the cash dividend to be paid by Golar LNG LimitedGLNGRelease · SEC
6:53 AM ET★★★★★Golar LNG reports interim results for period ended September 30, 2026GLNGRelease · SEC
6:47 AM ET★★★★★Nvidia third-quarter revenue reaches $115.84bn, up 103% year on yearNVDANews
★★★★★TG Therapeutics ranked number 5 on 2026 Deloitte Technology Fast 500TGTXRelease · Business Wire
★★★★★Amendment to Standby Equity Purchase Agreement raises commitment amount to $30,000,000MNDRRelease · SEC
6:00 AM ET★★★★★VisionWave announces partnership agreements to expand access to defense markets in Europe and AsiaVWAVRelease · GlobeNewswire
6:00 AM ET★★★★★Summit Therapeutics expands ivonescimab program with Phase III HARMONi-10 study in lung cancerSMMTRelease · Business Wire
6:00 AM ET★★★★★DataMeds AI Subsidiary Helomics Announces Cancer Target Discovery Partnership With DiaGen AIMEDSRelease · ACCESS Newswire
5:35 AM ET★★★★★Nvidia guides fourth-quarter revenue to $130 billion, above analyst average estimateNVDANews
4:59 AM ET★★★★★Recursion announces FDA alignment on registrational Phase 3 design for REC-4881 in FAPRXRXRelease · GlobeNewswire
4:32 AM ET★★★★★Nvidia holds back quarterly SEC report, departing from usual practiceNVDANews
4:25 AM ET★★★★★Uber and Momenta begin free robotaxi trials in MunichUBERNews
4:16 AM ET★★★★★Nvidia no longer shipping licensed Hopper data center chips to China, interim CEO saysNVDANews
4:00 AM ET★★★★★Nvidia forms national security board committee as petition for Huang's return passes 180,000 signaturesNVDANews
3:00 AM ET★★★★★Independent Data Monitoring Committee Recommends Cohort 3 at 15 mg/kg in ELEVATE-45-201TRDARelease
2:51 AM ET★★★★★Capricor's Deramiocel faces FDA target date Sunday after application narrowed to patients older than nineCAPRNews
2:10 AM ET★★★★★Nvidia commits over $1 billion to expand Kinsus substrate capacity in TaiwanNVDANews
2:00 AM ET★★★★★Nyxoah obtains default decision against Inspire Medical Systems in Unified Patent Court caseNYXHRelease · GlobeNewswire
1:57 AM ET★★★★★Samsung Electro-Mechanics expands Nvidia supply partnership for substrates and MLCCsNVDANews
1:19 AM ET★★★★★Nvidia hires search firm for permanent CEO; also among investors in Anthropic's $26 billion placementNVDANews
12:45 AM ET★★★★★Delta defends in-flight Wi-Fi as it awaits Amazon Leo rollout in 2028DALNews
12:45 AM ET★★★★★United targets full-fleet Starlink Wi-Fi by end of 2027 as Delta waits for Amazon LeoUALNews
12:40 AM ET★★★★★Interim CEO Kress says hyperscalers are not pulling back on Nvidia computeNVDANews
12:31 AM ET★★★★★Nvidia board says it will not reinstate Huang as CEONVDANews
11:35 PM ET★★★★★Red Cat withdraws 2026 revenue outlook, citing defense contract delays and uncertain fundingRCATNews
11:22 PM ET★★★★★Two Bloom Energy executives sell shares to cover tax withholding on RSU settlementBENews
11:06 PM ET★★★★★Nvidia says it will file its quarterly 10-Q in the coming weeks, later than usualNVDANews
10:55 PM ET★★★★★Nvidia to invest over $1B in cash in Kinsus for ABF substrate capacityNVDANews
10:38 PM ET★★★★★Commerce rules require licences for Nvidia chips shipped to five countries and curb remote accessNVDANews
10:18 PM ET★★★★★SpaceX CFO doubts Anthropic can quickly replace SpaceX compute, cites other customersSPCXNews
10:14 PM ET★★★★★Report: Former Nvidia sales head Puri had ties to customers in China chip diversion casesNVDANews
9:47 PM ET★★★★★Nvidia says AI infrastructure financing will continue, but selectively, with $118 billion in guaranteesNVDANews
9:41 PM ET★★★★★Maxim raises SELLAS price target to $40 from $30 after Phase 3 REGAL resultsSLSNews
8:44 PM ET★★★★★Nvidia's private equity stakes reach $65.5 billion as it reports $118 billion in guaranteesNVDANews
8:19 PM ET★★★★★Nvidia chair says board does not plan to bring Huang back as CEONVDANews
7:32 PM ET★★★★★Nvidia chairman rules out reinstating Huang as CEO; fourth-quarter revenue outlook givenNVDANews
7:13 PM ET★★★★★SpaceX CFO says business will fund much of AI compute expansion internallySPCXNews
7:09 PM ET★★★★★Interim CEO Kress lifts Nvidia FY28 revenue growth outlook to 75% from 70%NVDANews
7:07 PM ET★★★★★Kress says Nvidia is reviewing future investments, commitments and guarantees for AI customersNVDANews
6:58 PM ET★★★★★Nvidia's 10-Q filing will be delayed, investors toldNVDANews
6:37 PM ET★★★★★Nvidia ends H200 chip sales in China, acting CEO Kress says on earnings callNVDANews
6:32 PM ET★★★★★Nvidia chairman says board does not intend to reinstate Huang as CEONVDANews
6:02 PM ET★★★★★SpaceX CFO outlines 2027 start for solar-powered AI computing satellites on StarshipSPCXNews
6:00 PM ET★★★★★Nvidia board rules out reinstating Huang as CEO, announces $150 billion buyback and Q4 outlookNVDANews
5:36 PM ET★★★★★Marvell and Credo settle patent dispute over Active Electrical Cable technologyMRVLNews
5:32 PM ET★★★★★Nvidia says rental prices for its older chips are risingNVDANews
5:18 PM ET★★★★★NVIDIA expands commitments with supply chain partners to support AI infrastructure buildoutNVDARelease
5:17 PM ET★★★★★Nvidia flags $2.5 trillion cloud backlog amid growing AI adoptionNVDANews
★★★★★Oscar highlights tailored new health products in Texas for 2027 Open EnrollmentOSCRRelease · Business Wire
4:53 PM ET★★★★★Inhibrx announces updated clinical data for ozekibart (INBRX-109) in Ewing sarcomaINBXRelease · PR Newswire
4:50 PM ET★★★★★Aldeyra receives Nasdaq notice on minimum bid price requirementALDXFiling · SEC
4:35 PM ET★★★★★Oklo signs HALEU supply agreement with Centrus Energy Corp.OKLOFiling · SEC
4:35 PM ET★★★★★AST SpaceMobile files prospectus supplement covering 10,000,000 Firefly sharesASTSFiling · SEC
4:34 PM ET★★★★★NanoViricides amends at-the-market program, sets maximum offering at $8,376,444NNVCFiling · SEC
4:20 PM ET★★★★★NVIDIA reports third quarter fiscal 2027 revenue of $115.8 billionNVDARelease · SEC
4:17 PM ET★★★★★Report: SEC probing Nvidia following Huang's resignation as CEONVDANews
4:06 PM ET★★★★★Cheniere closes $1.2 billion offering of 5.800% senior notes due 2037LNGFiling · SEC
4:05 PM ET★★★★★Belite Bio files prospectus supplement for 203,699 warrant-exercise ADSsBLTEFiling · SEC
4:05 PM ET★★★★★Inovio Pharmaceuticals appoints Jeffrey Libson to board, expanding it to nine directorsINOFiling · SEC
4:05 PM ET★★★★★Amneal announces European approval of Adcomfo (omalizumab), a biosimilar to XOLAIRAMRXRelease · GlobeNewswire
4:05 PM ET★★★★★PacBio to participate in the Piper Sandler 38th Annual Healthcare ConferencePACBRelease · GlobeNewswire
4:05 PM ET★★★★★Akebia Therapeutics' Vafseo (vadadustat) Granted Additional PatentAKBARelease
4:02 PM ET★★★★★Artiva director Elizabeth Hougen resigns from boardARTVFiling · SEC
4:02 PM ET★★★★★Huang says he would be honored to return as Nvidia CEO if board decides soNVDANews
4:01 PM ET★★★★★Annexon reports inducement grants to new employees under Nasdaq Listing Rule 5635(c)(4)ANNXRelease · GlobeNewswire
4:01 PM ET★★★★★SELLAS Life Sciences announces proposed $150.0 million underwritten public offeringSLSRelease · GlobeNewswire
★★★★★Diranersen demonstrates increasing clinical benefit at two years in early Alzheimer's diseaseIONSRelease · Business Wire
3:32 PM ET★★★★★FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines WorldwideRegulatory · FDA
★★★★★Arrowhead Pharmaceuticals reports inducement grants under NASDAQ Listing Rule 5635(c)(4)ARWRRelease · Business Wire
★★★★★Stoke Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4)STOKRelease · Business Wire
2:15 PM ET★★★★★FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live LongerRegulatory · FDA
2:11 PM ET★★★★★Huang says he would return as Nvidia CEO if the board decides it is in shareholders' interestNVDANews
1:34 PM ET★★★★★Humacyte proposes governance reforms to settle stockholder derivative lawsuitsHUMANews
12:12 PM ET★★★★★Omeros shifts regulatory focus beyond EU after CHMP rejection; OMS527 trial start delayed to 2027OMERNews
12:01 PM ET★★★★★Huang says he would return as Nvidia CEO if the board decides it is warrantedNVDANews
11:22 AM ET★★★★★Seabourn announces annual Black Friday Sale with benefits on nearly all voyages through 2029CCLRelease · PR Newswire
11:06 AM ET★★★★★Huang says he would be honored to return as Nvidia CEO if board asksNVDANews
★★★★★Brazil publishes amended AST SpaceMobile satellite rightsASTSNews
★★★★★MannKind lists UBS Global Biopharma fireside chat in LondonMNKDNews
★★★★★MetaVia receives Nasdaq notice on stockholders' equity requirementMTVAFiling · SEC
★★★★★Redwire CEO reports November 16 common-share purchaseRDWFiling · SEC
★★★★★Senti announces one-for-thirty-three reverse splitSNTIRelease · GlobeNewswire
★★★★★Pooled THIO-101 disease control reaches 38 of 43 evaluable patientsMAIARelease

Load more news

Browse every company we cover in the Stock Hubs index, follow upcoming FDA and clinical dates in the Biotech Catalyst Calendar and download full reports from the Research Library.

Disclaimer. This page is published by Merlintrader for educational and informational purposes only. It does not constitute investment advice, an investment recommendation, an offer or a solicitation to buy or sell any security. Headlines summarize company announcements, regulatory filings and public records; readers should verify every item against the original document linked on each line before acting on it.

Small and mid-cap stocks, and biotech companies in particular, can move sharply on clinical, regulatory and financing news, and investors can lose all of the capital invested. Every reader is responsible for their own decisions and should consult a licensed financial adviser where appropriate. Merlintrader may hold positions in securities mentioned, and some links on this site are affiliate or referral links. Full legal information is available on the disclaimer and terms of use and privacy pages.